HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oligohydramnios

A condition of abnormally low AMNIOTIC FLUID volume. Principal causes include malformations of fetal URINARY TRACT; FETAL GROWTH RETARDATION; GESTATIONAL HYPERTENSION; nicotine poisoning; and PROLONGED PREGNANCY.
Networked: 661 relevant articles (32 outcomes, 63 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Fetal Distress
2. Preterm Premature Rupture of the Membranes
3. Acidosis
4. Fetal Growth Retardation (Intrauterine Growth Retardation)
5. Rupture

Experts

1. Wiznitzer, Arnon: 6 articles (01/2019 - 08/2007)
2. Magann, Everett F: 6 articles (01/2017 - 04/2007)
3. Hua, Ying: 5 articles (09/2022 - 06/2013)
4. Chauhan, Suneet P: 5 articles (11/2020 - 04/2007)
5. Macharey, Georg: 4 articles (01/2021 - 01/2017)
6. Chen, Chih-Ping: 4 articles (09/2020 - 12/2013)
7. Wang, Wayseen: 4 articles (09/2020 - 12/2013)
8. Sheiner, Eyal: 4 articles (06/2019 - 07/2008)
9. Sago, Haruhiko: 4 articles (01/2019 - 01/2008)
10. Yogev, Yariv: 4 articles (12/2014 - 06/2004)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Oligohydramnios:
1. Nitric Oxide (Nitrogen Monoxide)FDA Link
2. Dinoprostone (PGE2)FDA Link
3. Surface-Active Agents (Surfactants)IBA
4. Aquaporin 3IBA
5. Hemoglobins (Hemoglobin)IBA
6. Sildenafil Citrate (Viagra)FDA Link
7. Saline SolutionIBA
8. Dexamethasone (Maxidex)FDA LinkGeneric
9. AcidsIBA
10. Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA

Therapies and Procedures

1. Induced Labor
2. Therapeutics
3. Cesarean Section (Caesarean Section)
4. Fetal Version (External Cephalic Version)
5. Transplantation